These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863 [TBL] [Abstract][Full Text] [Related]
4. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis. Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843 [TBL] [Abstract][Full Text] [Related]
5. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. Rostami A; Ciric B J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791 [TBL] [Abstract][Full Text] [Related]
6. Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis. Khakzad MR; Ganji A; Ariabod V; Farahani I Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):348-353. PubMed ID: 28952817 [TBL] [Abstract][Full Text] [Related]
7. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700 [TBL] [Abstract][Full Text] [Related]
8. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway. You Z; Timilshina M; Jeong BS; Chang JH Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958 [TBL] [Abstract][Full Text] [Related]
9. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis. Yang EJ; Song IS; Song KS Phytomedicine; 2019 Feb; 54():56-65. PubMed ID: 30668383 [TBL] [Abstract][Full Text] [Related]
10. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation. Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304 [TBL] [Abstract][Full Text] [Related]
11. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice. Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908 [TBL] [Abstract][Full Text] [Related]
12. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response. Oh SJ; Chung DH J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032 [TBL] [Abstract][Full Text] [Related]
13. Artemisinin derivative TPN10466 suppresses immune cell migration and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis. Liu G; Jiang X; Han M; Lv J; Zhuang W; Xie L; Zhang Y; Wang C; Saimaier K; Yang J; Shen J; Li N; Du C Cell Immunol; 2022 Mar; 373():104500. PubMed ID: 35276582 [TBL] [Abstract][Full Text] [Related]
14. Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell. Li X; Li TT; Zhang XH; Hou LF; Yang XQ; Zhu FH; Tang W; Zuo JP PLoS One; 2013; 8(8):e74108. PubMed ID: 24009768 [TBL] [Abstract][Full Text] [Related]
15. Magnolol as STAT3 inhibitor for treating multiple sclerosis by restricting Th17 cells. Chen JY; Tian XY; Wei SS; Xu W; Pan RR; Chen LL; Chen LD; Nan LH; Yao-Lin ; Shan-Deng ; Wang QQ; Ma XQ; Huang MQ Phytomedicine; 2023 Aug; 117():154917. PubMed ID: 37301184 [TBL] [Abstract][Full Text] [Related]
16. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934 [TBL] [Abstract][Full Text] [Related]
17. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells. Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107 [TBL] [Abstract][Full Text] [Related]
18. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling. Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666 [TBL] [Abstract][Full Text] [Related]
19. Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response. Wu Z; Nagano I; Asano K; Takahashi Y Parasitol Res; 2010 Oct; 107(5):1173-88. PubMed ID: 20661746 [TBL] [Abstract][Full Text] [Related]
20. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses. Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]